intravitreal bevacizumab
Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates
... The present study showed that after 6 months, there was no beneficial effect of intravitreal bevacizumab for DME with subfoveal and perifoveal hard exudates in terms of visual acuity. Hard exudates ...
8
Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization
... PubMed Central and CAS, and is the official journal of The Society of Clinical Ophthalmology (SCO). The manuscript management system is completely online and includes a very quick and fair peer-review system, which is ...
10
The role of intravitreal bevacizumab in the management of various retinal vascular diseases
... P = 0.28, respectively) between previously treated and treatment naIve patients. There was no difference in OCT or visual acuity outcomes (P = 0.67 and P = 0.21, respectively) between patients who received combination ...
96
Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
... Figure 2 Spectral domain optical coherence tomography horizontal line scan of the left eye prior to development of vision loss, at presentation, and at last follow-up. Notes: Intact outer retinal structures centrally ...
5
Intravitreal Bevacizumab in Diabetic Macular Oedema
... Methods: intravitreal Bevacizumab injection ...of Bevacizumab with a mean of ...the intravitreal injection alone, 31 eyes (29%) had macular grid in conjunction with the intravitreal ...
6
Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion
... Results: The mean logMAR improved from 0.78 to 0.56 at 6 months for intravitreal bevacizumab (p=0.001), and from 0.91 to 0.79 and 0.87 at 3 and 6 months (p=0.038 and 0.13), respectively, for sub-tenon ...
7
Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab
... that intravitreal bevaci- zumab is effective in the treatment of vascular activity from presumed CNV associated with atypical choroidal nevi and that SD-OCT can be a useful tool in the follow-up of these patients, ...
6
The effect of intravitreal bevacizumab on ocular blood flow in diabetic retinopathy and branch retinal vein occlusion as measured by laser speckle flowgraphy
... Notes: images from a 65-year-old woman with BrVOMe in her left eye. Fundus color photographs (A and D), color lsFg maps (B and E), and axial OCT images at fovea (C and F) are shown. Pre-IVB findings are above (A, B, and ...
9
Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration
... We used intravitreal bevacizumab as one of the compo- nents of pulse triple therapy. It was also used as a mainte- nance therapy in our series. Use of an antiangiogenic factor can counteract the PDT induced ...
6
Safety of intravitreal bevacizumab as a monotherapy in ophthalmic conditions:systematic review
... to intravitreal bevacizumab (IVB) use and its quality in clinical ...for intravitreal injections as well as possible adverse events (AEs) associated with systemically administered ...anti-VEGFs. ...
22
Intravitreal Bevacizumab for the Treatment of Chronic or Recurrent Central Serous Chorioretinopathy
... of intravitreal bevacizumab injection (IVB) compared with low-fluence pho- todynamic therapy (L-PDT) in eyes with chronic central serous chorioretinopathy ...
9
Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
... Methods: A retrospective random case series study was performed. Twenty eyes of 20 patients who presented with neovascular glaucoma were treated with intravitreal bevacizumab 2.5 mg in 0.1 mL. Retinal ...
5
Hypotension Associated With Intravitreal Bevacizumab Therapy for Retinopathy of Prematurity
... Intravitreal bevacizumab therapy in preterm infants for retinopathy of prematurity (ROP) can be associated with ...after intravitreal bevacizumab therapy for ...Although ...
6
Intravitreal Bevacizumab Injection versus Intravitreal Bevacizumab Injection Followed by Macular Grid Laser Photocoagulation for Diabetic Macular Edema
... All patients were subjected to complete o p h t h a l m i c e x a m i n a t i o n i n c l u d i n g : Best corrected visual acuity (BCVA) measurements which were converted to their logMAR equivalents for statistical ...
10
Pharmacokinetics of intravitreal bevacizumab (Avastin<sup>®</sup>) in rabbits
... Four of the rabbits that received intravitreal injections of bevacizumab were sacrificed at each of the following days: 1, 3, 8, 15, and 29. Rabbits were first anesthetized with 20 mg/kg of intramuscular ...
8
Role of intravitreal bevacizumab in the treatment of neovascular glaucoma
... . In our study we have not monitored the role of PRP in the regression of neovascular changes. PRP before IVB was administered in 7 eyes out of 15 eyes (46%) and PRP post IVB in 9 eyes (60%). Three eyes (20%) received ...
90
Acute sterile endophthalmitis following intravitreal bevacizumab: case series
... Results: Ten patients presented sterile endophthalmitis with an onset time of 3.5±1.95 days. The clinical characteristics were mild pain, slight visual loss, conjunctival hyperemia, and various degrees of intraocular ...
7
Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up
... Material and methods: A prospective case series of 10 eyes of 10 consecutive patients affected by IPCV with subfoveal involvement. PDT plus IVB (1.25 mg/0.05 mL) injection two weeks later was performed in all patients. ...
5
The effect of intravitreal bevacizumab (Avastin<sup>®</sup>) on ocular pulse amplitude in neovascular age-related macular degeneration
... of bevacizumab or any other anti- VEGF treatment on OPA in AMD or in any other ocular ...off-label bevacizumab, at a ...of bevacizumab that reached the choriocapillaris within the first week post- ...
8
COMPARISON OF INTRAVITREAL BEVACIZUMAB (AVASTIN) WITH TRIAMCINOLONE FOR TREATMENT OF DIFFUSED DIABETIC MACULAR EDEMA: A PROSPECTIVE RANDOMIZED STUDYAli Kasiri, Fereydoun Farrahi, Mostafa Feghhi, Behnam Sadeghi, Hesam Hedayati, Seyed Ahmad Rasoulinejad DOWNLOAD/VIEW
... Diabetic macular edema (DME), is one of the most common causes of visual impairment in the diabetic patients [1]. The worldwide prevalence of diabetes is estimated to rise to 366 million by 2030 [2]. The 10-year ...
9